Allen Barnett - Athenex CoFounder Emeritus
| ATNXDelisted Stock | USD 0 0.00 0.00% |
Insider
Allen Barnett is CoFounder Emeritus of Athenex
| Phone | 716 427-2950 |
| Web | www.athenex.com |
Athenex Management Efficiency
The company has return on total asset (ROA) of (0.1965) % which means that it has lost $0.1965 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.2727) %, meaning that it created substantial loss on money invested by shareholders. Athenex's management efficiency ratios could be used to measure how well Athenex manages its routine affairs as well as how well it operates its assets and liabilities.Athenex currently holds 42.36 M in liabilities with Debt to Equity (D/E) ratio of 4.58, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Athenex has a current ratio of 1.28, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Athenex's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 9 records | INSIDER Age | ||
| Nancy Pecota | Adverum Biotechnologies | 64 | |
| DPHIL DPhil | CytomX Therapeutics | 57 | |
| MBA BS | CytomX Therapeutics | 45 | |
| Jim Wang | Adverum Biotechnologies | N/A | |
| Kishor JD | Adverum Biotechnologies | 53 | |
| Christopher Ogden | CytomX Therapeutics | 40 | |
| Brigit Riley | Adverum Biotechnologies | 46 | |
| Jamie Moore | CytomX Therapeutics | N/A | |
| Hoyoung MD | CytomX Therapeutics | 55 | |
Management Performance
| Return On Equity | -19.27 | |||
| Return On Asset | -0.2 |
Athenex Leadership Team
Elected by the shareholders, the Athenex's board of directors comprises two types of representatives: Athenex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Athenex. The board's role is to monitor Athenex's management team and ensure that shareholders' interests are well served. Athenex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Athenex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Allen Barnett, CoFounder Emeritus | ||
| Daniel MD, Pres Therapy | ||
| Jeffrey Yordon, COO and President Athenex Pharmaceutical Division | ||
| John Matthei, Chief Officer | ||
| Jacqueline Li, VP Devel | ||
| Caileigh Dougherty, Director Relations | ||
| Joe CFA, Chief Officer | ||
| BS MB, Chief Officer | ||
| FRCP MBBS, Chairman CEO | ||
| Steven Adams, Chief Officer |
Athenex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Athenex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -19.27 | |||
| Return On Asset | -0.2 | |||
| Profit Margin | (1.01) % | |||
| Operating Margin | (0.72) % | |||
| Current Valuation | 82.22 M | |||
| Shares Outstanding | 8.7 M | |||
| Shares Owned By Insiders | 9.73 % | |||
| Shares Owned By Institutions | 29.87 % | |||
| Number Of Shares Shorted | 356.33 K | |||
| Price To Earning | (4.87) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Athenex Stock
If you are still planning to invest in Athenex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athenex's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance |